InSphero gets funding from EUROSTARS for novel liver screening platform and opens new offices in Germany (05/12/2013)
InSphero has shown tremendous developments in the past months. Most recently, the company was awarded funding for a EUROSTARS project to develop a high-throughput compatible screening platform for the study of drug-induced liver injury, allowing not only for screening compounds potentially inflicting drug-induced liver injury but also for performing liver-related disease modeling. The project will [...] More.
Veeseo acquires more large German media players as customers (27/11/2013)
Veeseo, a Redalpine Capital I porfolio company, continues growing its customer base and is now cooperating with the well-known German media company Sport1.de.Sport1.de is Germany’s most popular online sports-portal with over 258 million page-impressions per month (June 2013). The subsidiary of the TV broadcaster Sport1 reports on a wide range of sports, including football, motorsports, [...] More.
Life Science Porfolio News: Redbiotec gets EU Grant, Biognosys gets US patent granted (30/10/2013)
Redbiotec, a Redalpine Capital I portfolio company, is one of the partners who were granted the Edufluvac project in the frame of the EU FP7-HEALTH package (EU overall contribution €4.6M). The project aims towards “universal” influenza vaccines, providing longer-lasting and broader protection against multiple strains of the virus, ultimately protecting the general population from seasonal [...] More.
The Typical Billion Dollar Startup Acquisition (10.12.2013)
Amazon To Look Into Deliveries By Self-Driving Car (06.12.2013)
Venture investing in Europe: Comeback capital (06.12.2013)